Colorectal cancer screening: potential pitfalls.
The National Health and Medical Research Council has recently issued guidelines on colo-rectal cancer, and given significant support to Colorectal Cancer Screening. However, the evidence of cost-effectiveness is inconclusive according to the Cochrane Centre. I argue that it would be wise to undertake trials that are appropriately funded. Otherwise, there is a risk that much money will be spent that cannot subsequently be justified.
Duggan
J
J
Centre for Clinical Epidemiology and Biostatistics, Faculty of Health Science, University of Newcastle.
D000328:Adult; D001315:Australia; D003113:Colonoscopy; D015179:Colorectal Neoplasms / Q000175:diagnosis / Q000517:prevention & control*; D003362:Cost-Benefit Analysis; D019317:Evidence-Based Medicine; D006801:Humans; D008403:Mass Screening / Q000191:economics*; D009780:Occult Blood; D017410:Practice Guidelines as Topic